EIS Eczacibasi Ilac, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S

Short Term Long Term Short Term Comparison Long Term Comparison
  • ECILC
  • 1d5.12%
  • 1w1.35%
  • 1m35.74%
  • 1y84.09%
ATH
  • ATH Price$0.00
  • ATH Date
  • % since ATHinf%
  • % to ATH0%
ATL
  • ATL Price$0.00
  • ATL Date
  • % from ATL0%
  • Last Low Price$0
  • Last Low Date
  • % From Last Low0%
IPO
  • IPO Price$0.00
  • % Current ROI USDN/A
  • ATH Price$0.00
  • % ROI ATH N/A
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="ECILC"]

Key Data [addtoany]

Current price $4.52
Sector Healthcare
Industry Drug Manufacturers—General
Today's High/Low $4.67/$4.28
Volume 132,205,637.00
Previous Close $4.3
52 Week High/Low $0/$0
Market Cap 3,111,080,448.00
P/E Ratio 18.3158
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.069
$4.52
[addtoany]

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses primarily in Turkey.
The company’s Health segment produces and sells human health and veterinary medicines. Its Real Estate Development segment develops real estate properties; and provides consulting services regarding land development and project management.
The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity